Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution GPK Q1 2026 Earnings EPS Beats Estimates by 56 Stock Edges Higher SPMA Q1 2026 Earnings Preferred Share Earnings Fall Short of Estimates AVIR Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment DUOL Q1 2026 Earnings EPS Surprises to the Upside as User Engagement Drives Results BBUC Q1 2026 Earnings Profitability Shines in a Quiet Quarter